HEART-TRANSPLANTATION IN CHILDREN - INDICATIONS AND OUTCOMES

Citation
J. Lebidois et al., HEART-TRANSPLANTATION IN CHILDREN - INDICATIONS AND OUTCOMES, Annales de pediatrie, 45(9), 1998, pp. 673-676
Citations number
2
Categorie Soggetti
Pediatrics
Journal title
ISSN journal
00662097
Volume
45
Issue
9
Year of publication
1998
Pages
673 - 676
Database
ISI
SICI code
0066-2097(1998)45:9<673:HIC-IA>2.0.ZU;2-F
Abstract
To date, 92 heart transplants have been performed as part of the pedia tric heart transplant program started at the Necker Enfants Malades/La ennec Hospital in Paris in 1987. One-third of patients were younger th an two years of age at transplantation, and nine were younger than nin e months. The most common reason for transplantation was cardiomyopath y (64%), which was usually of the dilated hypokinetic type; 33 patient s (36%) had congenital heart defects. Maintenance immunosuppressant th erapy usually consisted of cyclosporin and azathioprine, with in some cases Low-dose corticosteroid therapy. The postoperative complication rate was high. The most common early complication was acute rejection, whose diagnosis relied primarily on endomyocardial biopsy. Infections were.-very common during the first six months; after a phase of domin ant bacterial infections, viral infections became more common. Cyclosp orin caused renal dysfunction in some cases. Immunosuppressant-induced lymphoproliferative disorders occurred in eight patients and were sev ere in five. The main long-term complication was coronary artery disea se, which was responsible for complete coronary artery occlusion in so me cases. Mortality rates were about 22% during the first month and 26 % subsequently. Most late deaths were due to coronary artery disease, rejection, or lymphoproliferative syndrome. Most survivors enjoyed an excellent quality of life and were able to engage in normal physical a ctivities.